Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-096599
Filing Date
2021-03-26
Accepted
2021-03-26 16:28:04
Documents
7
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d226007d10k.htm 10-K 810885
2 EX-4.2 d226007dex42.htm EX-4.2 216792
3 EX-31.1 d226007dex311.htm EX-31.1 7382
4 EX-31.2 d226007dex312.htm EX-31.2 7375
5 EX-32.1 d226007dex321.htm EX-32.1 4496
6 EX-32.2 d226007dex322.htm EX-32.2 4476
7 GRAPHIC g226007g47m12.jpg GRAPHIC 98500
  Complete submission text file 0001193125-21-096599.txt   1188220
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39765 | Film No.: 21777778
SIC: 6770 Blank Checks